Holtway Global Hedge Pte. Ltd.
29.8.2024 13:11:47 CEST | ACCESS Newswire | Pressemeddelelse
Holtway Global Hedge, et førende globalt formueforvaltningsfirma med over 3 milliarder euro i forvaltede aktiver, bekræfter i dag sit engagement i at give kunder adgang til højpotentielle børsnoteringer (IPO'er). Hvis muligheden opstår, forbereder firmaet aktivt sine kunder på forventede muligheder i fremvoksende og innovative sektorer, herunder den meget omtalte børsnotering af SpaceX.
For at se dette indhold fra www.accesswire.com, så skal du give din accept på toppen af denne side."Hos Holtway Global Hedge forstår vi den transformerende kraft, som banebrydende virksomheder bringer til det offentlige marked," udtaler Kian Tan, administrerende direktør for Holtway Global Hedge. "Vi er dedikeret til at styrke vores kunder med muligheder for at deltage i væksten af disse innovative virksomheder. Vores ekspertise ligger i at identificere og evaluere højpotentielle børsnoteringer på tværs af forskellige sektorer, og vi er især begejstrede for udsigterne inden for den voksende rumteknologisektor, repræsenteret af virksomheder som SpaceX."
Holtway Global Hedge's dybe forståelse af globale markeder, kombineret med grundig forskning og analyse, gør det muligt for firmaet at identificere og evaluere børsnoteringer, hvilket sikrer, at kunderne er forberedte på disse investeringsmuligheder, når de opstår. Firmaet fokuserer primært på virksomheder i spidsen for innovation, såsom SpaceX, der revolutionerer rumteknologi og satellitinternetforbindelser, hvilket tilbyder betydeligt vækstpotentiale for investorer.
Med en stærk tilstedeværelse i Singapore og et globalt operationskontor i Canada tilbyder Holtway Global Hedge omfattende formueforvaltnings- og investeringsydelser til velhavende enkeltpersoner og familier på nøglemarkeder i Asien, Europa og Nordamerika. Deres team, der består af over 40 finansielle rådgivere og partnere, har samlet over 250 års erfaring inden for formueplanlægning, investeringsstyring og navigering af komplekse globale markeder. Denne ekspertise gør dem i stand til at tilbyde skræddersyede strategier, der er tilpasset hver enkelt kundes unikke finansielle rejse.
"Vi anvender en kundecentreret tilgang og sikrer, at hver investeringsstrategi er i overensstemmelse med vores kunders økonomiske mål og risikotolerance," tilføjede Tan. "Vores mål er at sætte vores kunder i stand til at træffe informerede beslutninger og opbygge diversificerede porteføljer, der inkluderer adgang til spændende børsnoteringer i sektorer som rumteknologi og andre fremvoksende industrier."
Om Holtway Global Hedge
Holtway Global Hedge er en betroet partner inden for global formueforvaltning, der tilbyder strategisk rådgivning og omfattende løsninger for at imødekomme kundernes forskellige behov over hele verden. Med en kundecentreret tilgang og fokus på langsigtet økonomisk succes giver Holtway Global Hedge enkeltpersoner og familier mulighed for at nå deres finansielle ambitioner.
For at se dette indhold fra www.accesswire.com, så skal du give din accept på toppen af denne side.For yderligere information om Holtway Global Hedge og deres markedsindsigt, besøg holtwayglobal.com eller kontakt:
Pressekontakt:
Li Wei Tan
Kommunikationsdirektør
Holtway Global Hedge
E-mail: media@holtwayglobal.com
Virksomhedskontaktoplysninger:
Holtway Global Hedge Pte. Ltd.
Telefon: +65 3125 6069
E-mail: info@holtwayglobal.com
SOURCE: Holtway Global Hedge Pte. Ltd.
View the original press release on accesswire.com
For at se dette indhold fra www.accesswire.com, så skal du give din accept på toppen af denne side.
Information om ACCESS Newswire
Følg pressemeddelelser fra ACCESS Newswire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra ACCESS Newswire
AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 15:45:00 CET | Press release
Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica
Preservica Redefines Digital Preservation with Powerful Built-In AI Tools4.2.2026 15:00:00 CET | Press release
OXFORD, UK and BOSTON, MA / ACCESS Newswire / February 4, 2026 / Preservica, the leader in AI-powered Active Digital Preservation™, today announced the rollout of integrated, human-centered AI tools and flexible AI Credits across its product editions. These new features make AI assistance a seamless part of everyday archival workflows, empowering organizations of all sizes to safely adopt AI and scale its use as their needs grow. "With the sheer volume of digital content in backlogs and being created daily, using AI to assist in archival tasks has now become essential" says Stuart Reed, Chief Product Officer at Preservica "Seamlessly integrating human-centered AI tools across our product editions turns AI for Digital Preservation into reality - enabling organizations of all sizes to accelerate routine work, cut backlogs and enhance discovery." Developed in collaboration with Preservica's user community and refined through the company's highly rated AI Workshop series, these embedded to
Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 15:00:00 CET | Press release
CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a
Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 14:00:00 CET | Press release
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in
CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 14:00:00 CET | Press release
TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
